Which has higher immunization, measles second dose, Iran or South Asia (IDA & IBRD)?

Iran, at 99.0% against 92.2% in South Asia (IDA & IBRD) as of 2024.

How many years of comparable data are there for Iran and South Asia (IDA & IBRD)?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Iran vs South Asia (IDA & IBRD): Immunization, measles second dose

Iran

99.0%

in 2024

South Asia (IDA & IBRD)

92.2%

in 2024

Iran rank

1st

South Asia (IDA & IBRD) rank

3rd

Immunization, measles second dose over time

Iran
South Asia (IDA & IBRD)

How they compare

Iran currently reports 99.0% against 92.2% in South Asia (IDA & IBRD), a difference of 6.8%.

That makes Iran's figure about 1.1 times South Asia (IDA & IBRD)'s.

Across all 25 years both countries report, Iran has been ahead every year.

Iran ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.

Iran has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Iran	South Asia (IDA & IBRD)	Difference	Ahead
2000s	96.6%	1.0%	95.6%	Iran
2010s	98.0%	57.5%	40.5%	Iran
2020s	98.4%	87.8%	10.6%	Iran

Averages of every year both report within each decade.

Frequently asked questions

Which has higher immunization, measles second dose, Iran or South Asia (IDA & IBRD)?: Iran, at 99.0% against 92.2% in South Asia (IDA & IBRD) as of 2024.
What is the difference in immunization, measles second dose between Iran and South Asia (IDA & IBRD)?: 6.8%, with Iran ahead.
How many years of comparable data are there for Iran and South Asia (IDA & IBRD)?: 25 years are reported by both, from 2000 to 2024.
How do Iran and South Asia (IDA & IBRD) rank globally for immunization, measles second dose?: Iran ranks 1st and South Asia (IDA & IBRD) ranks 3rd of 178 countries.
Where does this data come from?: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, measles second dose (% of children by the nationally recommended age). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Iran vs South Asia (IDA & IBRD): Immunization, measles second dose. Statizoid, drawing on WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Retrieved 17 September 2026, from https://health.statizoid.com/compare/immunization-measles-second-dose-percent-of-children-by-the-nationally-recommended-age/iran-islamic-rep/south-asia-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/immunization-measles-second-dose-percent-of-children-by-the-nationally-recommended-age/iran-islamic-rep/south-asia-ida-and-ibrd/">Iran vs South Asia (IDA & IBRD): Immunization, measles second dose</a> — Statizoid

About this data

Indicator: Immunization, measles second dose (% of children by the nationally recommended age)
Unit: % of children by the nationally recommended age
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 221 places, 4,472 data points, 1997–2024
Last refreshed: 03 September 2026

Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.